Goldman Sachs Starts Verve Therapeutics (VERV) at Sell
Tweet Send to a Friend
(Updated - December 15, 2022 3:59 AM EST)
Goldman Sachs analyst Andrea Tan initiates coverage on Verve Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Andrea Tan initiates coverage on Verve Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
